AOD-9604's entire human trial program involved 893 participants across six studies, with the largest being the 536-subject Phase 2b trial that failed to meet its endpoint
For clinicians, the most valuable outcome will be the data packet the FDA releases: seeing exactly what evidence they reviewed and what specific safety risks they identified will give us unprecedented clarity on where this peptide actually stands
GIP receptor activation is studied for its effects on adipose tissue metabolism and insulin secretion enhancement, while GLP-1 receptor activation is examined for its appetite suppression, gastric emptying delay, and pancreatic beta-cell protection
We also typically recommend cycling peptides, using them for a set period followed by a break, to maintain the bodys sensitivity and maximize results over the long term
This is the nuance the fear-based headlines always miss
The peptide chains within that cake are held in a fragile crystalline structure